- C
- N
- O
Calculated reference model · not an experimental or batch-certified structure. All 26 atoms shown.
Model data & sources
- Heavy atoms only; hydrogens are omitted from the reference display.
- Source-defined stereochemistry is checked against the calculated coordinates; no energy-minimum, crystal or solution-structure claim is made.
- Reference molecular species only; batch identity, purity, counterions and excipients are not certified.
- Formula
- C19H16N2O5
- Method
- RDKit ETKDGv3 / MMFF94s calculated reference conformer
- Batch
- KC-RXT-02
Roxadustat FG-4592
Research CompoundsPublished formats
- Dry-Fill Capsule 30ct/75mg/2.25g
- Powder 5g
What is the difference between these?
- Dry-Fill Capsule
- Capsules filled with the weighed solid. The label gives the amount in each capsule and the number in the bottle.
- Powder
- Raw material as a solid. Nothing added and nothing portioned; the stated weight is what is in the container.
Supplementary product details from the published catalog, checked 2026-10-07. These reference details do not establish current availability.
Pricing
Pricing and order placement are reserved for reviewed research accounts. Log in or submit an account application to view current product pricing.
Technical Specifications
Batch COA Database ↗Identity fields from the published product record, checked 2026-10-07. Reference information is not a batch identity certificate.
Research Overview
Roxadustat (FG-4592) Research Standard
Roxadustat (FG-4592, ASP 1517) is a potent, synthetic small-molecule inhibitor of the hypoxia-inducible factor prolyl hydroxylase (HIF-PH) enzymes. Characterized by an isoquinoline carboxamide scaffold, this compound serves as a critical biochemical tool for investigating oxygen-sensing pathways and cellular responses to hypoxia. In laboratory research, it is utilized as a competitive inhibitor to map enzyme-substrate interactions, assess binding affinity through kinetic assays, and probe the biochemical regulation of HIF-alpha subunit stability in isolated enzyme systems.
Physical & Handling Properties
| Property | Specification |
|---|---|
| Physical Appearance | White to pale green solid |
Mechanism of Action & Research Context
Roxadustat functions as a competitive inhibitor of the HIF-prolyl hydroxylase (PH) enzymes, which are responsible for the degradation of Hypoxia-Inducible Factor (HIF) under normoxic conditions.
-
Substrate Mimicry: The glycine amide group within the Roxadustat molecule acts as a mimetic of natural substrates, allowing the compound to occupy the enzyme's active site.
-
Active Site Binding: By binding to the site where oxygen and 2-oxoglutarate would normally interact, the molecule prevents the hydroxylation of HIF-alpha subunits.
-
Structural Stabilization: The phenoxy acetic acid moiety provides additional stability to the ligand-enzyme complex, allowing for the precise measurement of binding kinetics in cell-free assays.
Research Applications
Roxadustat is a specialized reagent used to investigate the kinetics and regulatory mechanisms of prolyl hydroxylase enzymes.
Primary fields of in vitro laboratory investigation include:
-
Enzyme Binding Assays: Measuring the efficacy of HIF-PH inhibition in isolated protein preparations and cell-free assay systems.
-
Competition Studies: Observing the displacement of natural substrates by Roxadustat to determine competitive binding characteristics.
-
Binding Affinity (Kinetics): Utilizing kinetic methods to establish inhibition constants and understand the stability of the enzyme-inhibitor complex.
-
Stability & Degradation Testing: Monitoring the chemical degradation of the compound under diverse environmental and solvent conditions to refine laboratory protocol standards.
Storage & Handling Guidelines
Store at controlled room temperature. Keep tightly closed.
Storage guidance is a house recommendation. Analytical documentation is per-lot release testing.
Related Research Compounds
Research Use Disclaimer
Research Use Only Disclaimer: This product is labeled and sold "For Research Use Only — NOT FOR HUMAN CONSUMPTION." It is not a drug, dietary supplement, food, cosmetic, or medical device, and it is not approved by the FDA or any other regulator for human or veterinary use. It is supplied to approved account holders as a research chemical for laboratory use and must be handled in accordance with applicable law.
Currently shipping from batch KC-RXT-02.

Compounds That Survive Scrutiny
Research use only. Not for human or veterinary use.